The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases

Abstract

Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders.

Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders

“…Neurodegenerative diseases are closely linked to the disruption in neurotransmitter systems. 68 In particular, PD and AD are characterized by neurotransmitter dysregulation. The brain's levels of acetylcholine and dopamine are reduced by cholinesterase and monoamine oxidase B, contributing to AD and PD.…”

“…Neurodegenerative diseases are closely linked to the disruption in neurotransmitter systems 68 . In particular, PD and AD are characterized by neurotransmitter dysregulation.…”

Effects of Bradykinin B2 Receptor Ablation from Tyrosine Hydroxylase Cells on Behavioral and Motor Aspects in Male and Female Mice

“…The neuronal activity of monoamines is a pivotal indicator for various conditions encompassing depression, anxiety, and other neurodegenerative diseases that intricately influence the dopaminergic system [36]. In this study, we investigated the impact of B2R deletion in TH-expressing cells on the concentrations of monoamines and their metabolites in the SN and cerebral cortex of both female and male mice.…”

Ultraflexible PEDOT:PSS/IrOx-Modified Electrodes: Applications in Behavioral Modulation and Neural Signal Recording in Mice

“…Owing to the superior signal quality and resolution offered by deep brain electrodes, implantable deep brain probes have attracted considerable attention and investigation. Serving as devices that can both monitor and stimulate the nervous system, deep neural interfaces have been widely applied in neuroscientific research, such as mapping neural circuits, as well as in the treatment of neurodegenerative diseases like Parkinson's disease, epilepsy, and amyotrophic lateral sclerosis (ALS) [1,2]. Deep neural probes can capture high-resolution local field potentials (LFPs) and discern the firing activity of individual neurons [3].…”